Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug
![stethoscope and table on white background](/sites/g/files/oketem336/files/styles/3_2_480x320/public/media/images/stethoscope_3600x2700.jpg.webp?itok=Xr2XDet4)
Dr. Keith Vossel, Neurologist and Director of the Easton Center, was quoted in a San Francisco Chronicle July 7th article about more observations and real-world data needed to determine the effectiveness of the newly approved Alzheimer’s drug, Leqembi.
Read San Francisco Chronicle Article